ELN-DAVID is active in the following areas:
Exchange and collaboration
Supporting interaction and co-operation between clinical experts (physicians, study groups) and scientific/research groups on AML and related scientific areas on an international level.
Regular organisation of meetings and conferences for promotion of the activities described above.
Standardisation and quality control
Achieving general standards with respect to:
Harmonization / standardization and quality control of MRD assessment in AML patients, development of guidelines on MRD assessment in AML patients and the implementation and/or harmonization of clinical trials involving MRD on AML and related diseases
Generation of clinical evidence
Development and promotion of clinical, translational and basic research activities on AML and related diseases with a focus on measurable residual disease (MRD).